Search research articles
Contact Us
Filters
Showing results (171-180 of 280) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2014
Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial
Emmanouil Fokas, Torsten Liersch, Rainer Fietkau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2005
Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results
Torsten Liersch, Johannes Meller, Bettina Kulle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 26, 2022
Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials
Markus Diefenhardt, Maximillian Fleischmann, Daniel Martin, et al.
Plos One
|
October 1, 2020
KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer
Peter Jo, Markus Bernhardt, Manuel Nietert, et al.
Biomedicines
|
February 24, 2024
Perioperative LiMAx Test Analysis: Impact of Portal Vein Embolisation, Chemotherapy and Major Liver Resection
Felix Rühlmann, Azadeh Azizian, Christian Moosmann, et al.
International Journal of Cancer
|
April 17, 2024
ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer
Yuuki Ohara, Huaitian Liu, Amanda J Craig, et al.
Langenbeck'S Archives of Surgery
|
July 27, 2024
Role of liver augmentation prior to hepatic resection - a survey on standards, procedures, and indications in Germany, Switzerland, and Austria
Elif Yilmaz, Giovanni F Torsello, Ali Seif Amir Hosseini, et al.
Carcinogenesis
|
February 17, 2024
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism
Yuuki Ohara, Amanda J Craig, Huaitian Liu, et al.
Diseases of the Colon and Rectum
|
April 7, 2016
Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup
Thilo Sprenger, Hilka Rothe, Lena-Christin Conradi, et al.
Cancers
|
June 2, 2021
Volumetric Modulated Arc Therapy Improves Outcomes in Definitive Radiochemotherapy for Anal Cancer Whilst Reducing Acute Toxicities and Increasing Treatment Compliance
Jacqueline Possiel, Hanne Elisabeth Ammon, Manuel Guhlich, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 280) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2014
Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial
Emmanouil Fokas, Torsten Liersch, Rainer Fietkau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2005
Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results
Torsten Liersch, Johannes Meller, Bettina Kulle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 26, 2022
Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials
Markus Diefenhardt, Maximillian Fleischmann, Daniel Martin, et al.
Plos One
|
October 1, 2020
KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer
Peter Jo, Markus Bernhardt, Manuel Nietert, et al.
Biomedicines
|
February 24, 2024
Perioperative LiMAx Test Analysis: Impact of Portal Vein Embolisation, Chemotherapy and Major Liver Resection
Felix Rühlmann, Azadeh Azizian, Christian Moosmann, et al.
International Journal of Cancer
|
April 17, 2024
ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer
Yuuki Ohara, Huaitian Liu, Amanda J Craig, et al.
Langenbeck'S Archives of Surgery
|
July 27, 2024
Role of liver augmentation prior to hepatic resection - a survey on standards, procedures, and indications in Germany, Switzerland, and Austria
Elif Yilmaz, Giovanni F Torsello, Ali Seif Amir Hosseini, et al.
Carcinogenesis
|
February 17, 2024
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism
Yuuki Ohara, Amanda J Craig, Huaitian Liu, et al.
Diseases of the Colon and Rectum
|
April 7, 2016
Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup
Thilo Sprenger, Hilka Rothe, Lena-Christin Conradi, et al.
Cancers
|
June 2, 2021
Volumetric Modulated Arc Therapy Improves Outcomes in Definitive Radiochemotherapy for Anal Cancer Whilst Reducing Acute Toxicities and Increasing Treatment Compliance
Jacqueline Possiel, Hanne Elisabeth Ammon, Manuel Guhlich, et al.
Page
of 28